These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11081260)

  • 1. Multiple papillary thyroid carcinoma metastases revealed on position emission tomography scan in a patient with negative 131I scan.
    Mechanick JI; Kim CK; Krynyckyi BR; Machac J; Urken ML
    Thyroid; 2000 Oct; 10(10):929-30. PubMed ID: 11081260
    [No Abstract]   [Full Text] [Related]  

  • 2. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
    Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
    J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [PET-FDG in thyroid cancer with high thyroglobulin levels and negative 131-I scan. A case report].
    Ortega F; Maldonado A; Marañes P; Montz R; Pérez-Castejón MJ; Melgarejo M; Ruiz JA; Carreras JL
    Rev Esp Med Nucl; 1999; 18(1):50-4. PubMed ID: 10074219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical lymph node metastasis of thyroid papillary carcinoma imaged with fluorine-18-FDG, technetium-99m-pertechnetate and iodine-131-sodium iodide.
    Scott GC; Meier DA; Dickinson CZ
    J Nucl Med; 1995 Oct; 36(10):1843-5. PubMed ID: 7562053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma.
    Alnafisi NS; Driedger AA; Coates G; Moote DJ; Raphael SJ
    J Nucl Med; 2000 Jun; 41(6):1010-5. PubMed ID: 10855626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer.
    Feine U; Lietzenmayer R; Hanke JP; Held J; Wöhrle H; Müller-Schauenburg W
    J Nucl Med; 1996 Sep; 37(9):1468-72. PubMed ID: 8790195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of F-18 FDG to I-123 and I-131 scans in thyroid carcinoma.
    Bakheet SM; Powe JE; Hammami MM; Ahmed M
    Clin Nucl Med; 1997 Jun; 22(6):438-9. PubMed ID: 9193832
    [No Abstract]   [Full Text] [Related]  

  • 8. Localization of concomitant metastases to kidney and erector spinae from papillary thyroid carcinoma using (131)I-SPECT and CT.
    Luo Q; Luo QY; Sheng SW; Chen LB; Yu YL; Lu HK; Zhu RS
    Thyroid; 2008 Jun; 18(6):663-4. PubMed ID: 18578619
    [No Abstract]   [Full Text] [Related]  

  • 9. [Papillary thyroid carcinoma metastasis to parapharyngeal lymph nodes: interest of the PET scan].
    Turner F; Paris J; Giovanni A; Zanaret M
    Rev Laryngol Otol Rhinol (Bord); 2006; 127(3):175-8. PubMed ID: 17007192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor thrombus in the great veins from papillary carcinoma of the thyroid: 131I scan findings.
    Mugunthan N; Kumar AR; Thomas P
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2527-8. PubMed ID: 20525903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenal metastasis secondary to papillary thyroid carcinoma.
    Koutkia P; Safer JD
    Thyroid; 2001 Nov; 11(11):1077-9. PubMed ID: 11762719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [18FDG whole-body PET in differentiated thyroid carcinoma. Flipflop in uptake patterns of 18FDG and 131I].
    Feine U; Lietzenmayer R; Hanke JP; Wöhrle H; Müller-Schauenburg W
    Nuklearmedizin; 1995 Aug; 34(4):127-34. PubMed ID: 7675641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic parotid tumor: a rare presentation for papillary carcinoma of thyroid.
    Malhotra G; Nair N; Awasare S; Baghel NS
    Clin Nucl Med; 2007 Jun; 32(6):488-90. PubMed ID: 17515766
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 131I and recombinant human thyroid stimulating hormone.
    Rudavsky AZ; Freeman LM
    J Clin Endocrinol Metab; 1997 Jan; 82(1):11-4. PubMed ID: 8989223
    [No Abstract]   [Full Text] [Related]  

  • 15. Upper retropharyngeal node involvement in differentiated thyroid carcinoma demonstrated by 131I scintigraphy.
    Leger AF; Baillet G; Dagousset F; Vincenot MI; Izembart M; Clerc J; Barritault L
    Br J Radiol; 2000 Dec; 73(876):1260-4. PubMed ID: 11205668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131.
    Park HM; Perkins OW; Edmondson JW; Schnute RB; Manatunga A
    Thyroid; 1994; 4(1):49-54. PubMed ID: 8054861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic papillary thyroid carcinoma presenting as a long-standing calcified neck mass.
    Grosz AH; Sauer DA; Bliziotes MM; Cohen JI; Gross ND
    Thyroid; 2007 Aug; 17(8):799-800. PubMed ID: 17725440
    [No Abstract]   [Full Text] [Related]  

  • 18. Rectus abdominis muscle metastasis from papillary thyroid cancer identified by I-131 SPECT/CT.
    Zhao LX; Li L; Li FL; Zhao Z
    Clin Nucl Med; 2010 May; 35(5):360-1. PubMed ID: 20395716
    [No Abstract]   [Full Text] [Related]  

  • 19. I-131 whole body scintigraphy in a patient with micronodular pulmonary metastases from papillary thyroid carcinoma.
    Ruíz Hernández G; Vázquez Forner C; Fliquete Peris MV
    Nuklearmedizin; 2000; 39(1):40-1. PubMed ID: 10726257
    [No Abstract]   [Full Text] [Related]  

  • 20. Thallium-201 uptake with negative iodine-131 scintigraphy and serum thyroglobulin in metastatic oxyphilic papillary thyroid carcinoma.
    Harder W; Lind P; Molnar M; Mikosch P; Gomez I; Gallowitsch HJ; Kresnik E; Unterweger O; Dinges HP
    J Nucl Med; 1998 Feb; 39(2):236-8. PubMed ID: 9476925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.